4
Changes in Ownership
Nautilus Biotechnology, Inc. Filed Acc 0001234663-26-000002
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NAZEM FARZAD · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +45,000 | 45,000 | D |
Loading xslF345X06/wk-form4_1782159243.xml…